Park Ha Biological Technology Co., Ltd. (BYAH)

BYAH Income Statement

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	FY 2026	FY 2025	FY 2023	FY 2022	FY 2021
Period Ending	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021
Revenue	2.52	2.38	2.46	1.92	0.93
Revenue Growth (YoY)	6.00%	-3.14%	28.12%	106.16%	-
Cost of Revenue	0.14	0.2	0.31	0.51	0.31
Gross Profit	2.38	2.19	2.15	1.41	0.62
Selling, General & Admin	26.11	1.18	0.78	1.15	1.12
Research & Development	0.24	0.04	0.03	0.06	-
Other Operating Expenses	0.18	0.18	0.15	0.01	-
Total Operating Expenses	26.53	1.39	0.97	1.21	1.12
Operating Income	-24.15	0.79	1.18	0.2	-0.5
Interest Income	0.01	0	0	0	0
Interest Expense	-0	-	-	-0	-0
Other Non-Operating Income (Expense)	0.06	-0	-0	-0.01	0.02
Total Non-Operating Income (Expense)	0.06	-0	0	-0.01	0.02
Pretax Income	-24.08	0.79	1.18	0.19	-0.48
Provision for Income Taxes	0.28	0.31	0.33	-0	-
Net Income	-24.36	0.48	0.85	0.19	-0.48
Net Income to Common	-24.36	0.48	0.85	0.19	-0.48
Net Income Growth	-	-43.83%	345.40%	-	-
Shares Outstanding (Basic)	1	1	1	1	1
Shares Outstanding (Diluted)	1	1	1	1	1
Shares Change (YoY)	17.77%	-	-	-	-
EPS (Basic)	-41.38	0.96	1.70	0.50	-1.00
EPS (Diluted)	-41.38	0.96	1.70	0.50	-1.00
EPS Growth	-	-43.53%	240.00%	-	-
Shares Outstanding	0.68	-	-	-	-
Free Cash Flow	-0	0.87	0.1	1.43	-0.51
Free Cash Flow Growth	-	742.38%	-92.74%	-	-
Free Cash Flow Per Share	-0.01	1.75	0.21	2.86	-1.02
Gross Margin	94.36%	91.80%	87.35%	73.47%	66.58%
Operating Margin	-956.45%	33.32%	48.01%	10.26%	-53.81%
Profit Margin	-965.00%	20.09%	34.65%	9.97%	-52.09%
FCF Margin	-0.12%	36.73%	4.22%	74.52%	-54.86%
EBITDA	-24.04	0.82	1.2	0.23	-0.46
EBITDA Margin	-952.12%	34.28%	48.82%	11.85%	-49.62%
EBIT	-24.15	0.79	1.18	0.2	-0.5
EBIT Margin	-956.45%	33.32%	48.01%	10.26%	-53.81%
Effective Tax Rate	-1.17%	39.68%	27.89%	-0.68%	0.00%

Updated Oct 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.